• Users Online: 535
  • Print this page
  • Email this page
This article has been cited by
1Intravitreal dexamethasone implant as an alternative to systemic steroids as prophylaxis for uveitic cataract surgery: a randomized trial
Aditya Sudhalkar,Abhay Vasavada,Deepak Bhojwani,Viraj Vasavada,Shail Vasavada,Vaishali Vasavada,Samaresh Srivastava
Eye.2020;34(3)491
[DOI]
2Predictive capacity of baseline hyperreflective dots on the intravitreal dexamethasone implant (Ozurdex®) outcomes in diabetic macular edema: a multicenter study
Alejandro Fonollosa,Javier Zarranz-Ventura,Alicia Valverde,Erika Becerra,Carolina Bernal-Morales,Salvador Pastor-Idoate,Miguel Angel Zapata
Graefe's Archive for Clinical and Experimental Ophthalmology.2019;257(11)2381
[DOI]
3Early versus late switch: How long should we extend the anti-vascular endothelial growth factor therapy in unresponsive diabetic macular edema patients?
Adrian Hernández Martínez,Ernesto Pereira Delgado,Guillermo Silva Silva,Luis Castellanos Mateos,José Lorente Pascual,Julian Lainez Villa,Paula García Vicente,Carmen-Victoria Almeida-González
European Journal of Ophthalmology.2019;257(11)112067211984825
[DOI]
4Safety of 6000 intravitreal dexamethasone implants
Bindu Rajesh,Javier Zarranz-Ventura,Adrian T Fung,Catharina Busch,Niroj Kumar Sahoo,Patricio J Rodriguez-Valdes,Valentina Sarao,Sanjay Kumar Mishra,A Osman Saatci,Patricia Udaondo Mirete,Giuseppe Querques,Michel Eid Farah,Paolo Lanzetta,J Fernando Arevalo,Laurent Kodjikian,Jay Chhablani
British Journal of Ophthalmology.2020;104(1)39
[DOI]
5Pro Re Nata Dexamethasone Implant for Treatment-Naive Phakic Eyes with Diabetic Macular Edema
Alper Bilgic,Aditya Sudhalkar,Laurent Kodjikian,Viraj Vasavada,Shail Vasavada,Deepak Bhojwani,Vaishali Vasavada,Samaresh Srivastava
Ophthalmology Retina.2019;3(11)929
[DOI]